Rare copy number variants or CNVs appear to play a significant role in the bipolar disorder, say University of California researchers.
The findings will be published in the December 22 issue of the journal Neuron.
Bipolar Disorder
Bipolar Disorder is a brain disorder in which people show "mood swings". Changes in the level of neurotransmitters in brain, and psychosocial factors are thought to be involved.
Advertisement
CNVs are genomic alterations in which there are too few or too many copies of sections of DNA. Researchers have known that spontaneously occurring (de novo) CNVs - genetic mutations not inherited from parents - significantly increase the risk for some neuropsychiatric conditions, such as schizophrenia or the autism spectrum disorders. But their role was unclear in bipolar disorder, previously known as manic depression.
Principal investigator Jonathan Sebat, PhD, assistant professor of psychiatry and cellular and molecular medicine at UC San Diego''s Institute of Genomic Medicine, and colleagues, found that de novo CNVs contribute significant genetic risk in about 5 percent of early onset bipolar disorder, which appears in childhood or early adulthood.
![Schizophrenia]( "Schizophrenia")
Schizophrenia is a mental disorder characterized by symptoms of thought, behavior and social problems.
In other words, said the study''s first author Dheeraj Malhotra, assistant project scientist in Sebat''s lab, "having a de novo mutation increases the chances of having an earlier onset of disease."
The cause or causes of bipolar disorder remain unclear. There is a clear genetic component - the disease runs in families - but previous studies that have focused mainly on common inherited variants have met with limited success in identifying key susceptibility genes.
Malhotra said that - while the findings do not conclusively pinpoint a specific gene or genomic region -- the new findings show "convincing" evidence that rare copy number mutations strongly contribute to the development of early onset bipolar disorder. He added that sequencing of complete genomes or exomes of large number of bipolar families is needed to determine the total genetic contribution of all forms of de novo mutation to risk for bipolar disorder.
Source: Newswise
Schizophrenia
Schizophrenia is a mental disorder characterized by symptoms of thought, behavior and social problems.
Advertisement
In other words, said the study''s first author Dheeraj Malhotra, assistant project scientist in Sebat''s lab, "having a de novo mutation increases the chances of having an earlier onset of disease."
The cause or causes of bipolar disorder remain unclear. There is a clear genetic component - the disease runs in families - but previous studies that have focused mainly on common inherited variants have met with limited success in identifying key susceptibility genes.
Malhotra said that - while the findings do not conclusively pinpoint a specific gene or genomic region -- the new findings show "convincing" evidence that rare copy number mutations strongly contribute to the development of early onset bipolar disorder. He added that sequencing of complete genomes or exomes of large number of bipolar families is needed to determine the total genetic contribution of all forms of de novo mutation to risk for bipolar disorder.
Source: Newswise
Autism
Autism is a neurodevelopmental disorder typically characterized by impaired social and communication skills combined with repetitive movements.
Advertisement
 Quiz on BrainThe human brain is exquisitely intrinsic and is the seat of all emotions. If you are curious about what makes you bad, sad, silly or glad this quiz on the brain will satiate you. | Advertisement
|
Advertisement
Recommended Readings
Latest Mental Health News
Schizophrenic patients have a genetic link to increased cardiovascular risk factors, especially smoking and body mass index.
Mental health issues such as anxiety and depression could be precursors to multiple sclerosis (MS), even before the classic MS symptoms appear.
Studying brain circuits tied to PTSD's progression from acute to chronic states is vital for grasping its pathophysiology and crafting targeted treatments.
Older adults with COPD were roughly twice as likely to develop depression if they faced functional limitations.
In most scenarios, depression screening tools demonstrated superior performance compared to suicide risk screenings.
